Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02022943 · ClinicalTrials.gov registry record

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

A clinical trial of Dementia and Alzheimers Disease, sponsored by Banner Health.

Recruiting
Registry status
500,000
Enrollment target
1
Study location

NCT02022943 is a study of Dementia and Alzheimers Disease that is actively recruiting participants, run by Banner Health. The registered enrollment target is 500,000 participants, above the 5,210-participant average among 199 other Dementia trials with a reported enrollment target (9497% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02022943, a study of Dementia and Alzheimers Disease, is actively recruiting participants, sponsored by Banner Health.

RECRUITING
Registry status
500,000 participants
Enrollment target
1
Study location

Study Summary

The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org

Study Locations (1)

Arizona

  • Banner Alzheimer's Institute - Phoenix

Trial Details

FieldValue
Enrollment Target 500,000 participants
Start Date 2012-05
Est. Completion 2030-01

Sponsor

Banner Health

8 total trials

What the Registry Record Tells You About NCT02022943

The ClinicalTrials.gov registry entry for NCT02022943 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 5,210-participant average among 199 other Dementia trials with a reported enrollment target (9497% higher). The listed sponsor is Banner Health, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Dementia appearing as the primary indexed condition, and to 0 interventions.

NCT02022943 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.

Frequently Asked Questions

What is clinical trial NCT02022943 about?

NCT02022943 is a clinical study titled "Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies". The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolle...

What is the current status of trial NCT02022943?

This trial is currently recruiting. The enrollment target is 500,000 participants. The study started on 2012-05. Estimated completion is 2030-01.

What conditions does trial NCT02022943 study?

This clinical trial studies the following conditions: Dementia, Alzheimers Disease.

Who is sponsoring clinical trial NCT02022943?

This trial is sponsored by Banner Health, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02022943 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dementia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.